D. O’Driscoll

A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

M. Martí-Renom, E. López de Maturana, L. Alonso, 2020, bioRxiv.

Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches

N. Malats, M. Márquez, A. Carrato, 2018, International journal of cancer.

Reduced risk of pancreatic cancer associated with asthma and nasal allergies

N. Malats, M. Márquez, A. Carrato, 2015, Gut.

Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

N. Malats, M. Márquez, A. Carrato, 2021, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

N. Malats, M. Márquez, A. Carrato, 2020, Gut.

Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland.

H. Comber, A. Carsin, L. Sharp, 2009, European journal of cancer.

A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk

N. Malats, M. Márquez, A. Carrato, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose–Response Relationships

N. Malats, M. Márquez, A. Carrato, 2020, Cancer Epidemiology, Biomarkers & Prevention.

Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives.

N. Malats, M. Márquez, A. Carrato, 2018, International journal of epidemiology.

Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

N. Malats, M. Márquez, A. Carrato, 2021, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

HLA-A*02:01 allele is associated with decreased risk and a longer survival in pancreatic cancer: Results from an exhaustive analysis of the HLA variation in PDAC

L. Alonso, A. Carrato, A. Tardón, 2024, medRxiv.